Our people
What we do
Industries Practices Legal Tech

Aerospace and Defense

Automotive and Mobility

Consumer

Education

Energy and Natural Resources

Financial Institutions

Insurance

Life Sciences and Health Care

Manufacturing and Industrials

Private Capital

Real Estate

Sports, Media and Entertainment

Technology and Telecoms

Transportation and Logistics

Corporate & Finance

Disputes

Intellectual Property, Media, and Technology

Regulatory
Case studies
Our thinking
ESG
Careers

Search

Search

Deutsch
English
Español
Français
日本語
中文

About us
Where we are
Media center
Events and webinars
Responsible Business
Alumni

Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Resources

Premium services

Click here to learn more about our range of premium tools

Distressed Banks

Navigate the legal implications relating to banks in distress with our resource center.

Supply Chains

Access our latest insights into supply chain risk management and governance.

Comparative guides

View the global picture with our interactive comparative guides

Publications

Search

No results found

2

Filter by type

Hogan Lovells Publications
Insights and Analysis
News
Published Works

Aerospace and Defense
Automotive and Mobility
Consumer
Education
Energy and Natural Resources
Financial Institutions
Insurance
Life Sciences and Health Care
Manufacturing and Industrials
Private Capital
Real Estate
Sports, Media and Entertainment
Technology and Telecoms
Transportation and Logistics

Administrative and Public Law
Antitrust and Competition
Aviation
Business and Human Rights
Capital Markets
Commercial
Commercial Litigation
Communications, Internet, and Media
Complex Contracting
Copyright
Corporate and Securities Litigation
Corporate Governance and Public Company Representation
Crisis Leadership Team
Designs
Digital Assets and Blockchain
Domain Names
Education
Employment
Energy Regulatory
Environment and Natural Resources
Executive Compensation, Employee Benefits, and Share Incentives
Financial Services
Food Law
Government Contracts
Government Relations and Public Affairs
Health
Infrastructure, Energy, Resources, and Projects
Insolvency Litigation
Intellectual Property
International Arbitration
International Trade and Investment
International Trade Commission Section 337
Investigations, White Collar, and Fraud
IP and Technology Transactions
IP Litigation, Arbitration, and Alternative Dispute Resolution
Joint Ventures
Litigation Services
Marketing and Advertising
Medical Device and Technology Regulatory
Mergers and Acquisitions
Nuclear Energy and Materials
Patents
Pharmaceuticals and Biotechnology Regulatory
Privacy and Cybersecurity
Private Equity
Products Law
Public Procurement
Real Estate
Real Estate Finance
Restructuring and Special Situations
Securities and Public Company Advisory
Sovereigns
Strategic Operations, Agreements and Regulation
Technology Litigation
Trade Secrets and Confidential Know-how
Trademarks and Brands
Transportation
Uncrewed Aircraft Systems (UAS)
Venture Capital and Emerging Companies

China Trade and Security
Data Centers
Environmental, Social, and Governance (ESG)
European Green Deal
Eye on DC: Legislative and Regulatory Developments from the U.S. Capitol
Real Estate Horizons
Regulatory, Compliance & Investigation Solutions
Supply Chain Legal Issues
UK2030: defining a path to global business competitiveness

2024
2023
2022
2021

News

Scrutiny on health care professional transparency and inducement in the Netherlands

08 May 2024

On 8 April 2024, the Dutch Minister of Medical Care sent a letter to Dutch Parliament (in Dutch: “Tweede Kamer”) regarding interactions between life sciences companies and...

Insights and Analysis

Life Science Law Update – Key developments for pharma & device companies in EU

07 May 2024

The Q1/24 Life Science and Health Care Law Update covers key trends across EU life sciences regulatory, corporate, compliance, competition, and privacy.Key new developments: Pharma: EC ...

News

HHS finalizes changes to Section 1557 regulations strengthening anti-discrimination protections

07 May 2024

On April 26, 2024, the U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) and the Centers for Medicare & Medicaid Services (CMS) finalized updates to...

News

CMS Issues Draft Guidance on Inflation Reduction Act (IRA) Drug Price Negotiation Program for 2027

06 May 2024

On May 3, 2024, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for initial price applicability year (IPAY) 2027 of the Drug Price Negotiation Program...

News

FDA under fire: Pared-down LDT Final Rule leaves unanswered questions

06 May 2024

The U.S. Food and Drug Administration (FDA) has finalized its historic — and notoriously controversial — rule to explicitly assert the agency’s authority to regulate...

News

FTC disputes new slate of Orange Book patents for weight loss, diabetes, asthma, and COPD drugs

06 May 2024

On April 30, 2024, the Federal Trade Commission (FTC) announced that it sent a new set of warning letters to ten pharmaceutical companies. The letters inform the companies that the...

News

CMS finalizes new standards and reporting obligations affecting Medicaid and CHIP managed care plans

02 May 2024

On April 22, 2024, the Centers for Medicare & Medicaid Services (CMS) issued the Medicaid and Children's Health Insurance Program (CHIP) Managed Care Access, Finance, and Quality...

Insights and Analysis

Hogan Lovells 2024 M&A Outlook

01 May 2024

Our 10th annual M&A Year in Review features a 2024 M&A Outlook, which provides insights across the key topics that we expect will influence dealmaking in the months to come:...

News

UK MHRA Publishes AI Regulatory Strategy

01 May 2024

On 30 April 2024, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) published its strategic approach to AI and the steps it is taking to implement the UK Government's AI ...

Load more

Stay in the know Subscribe

Connect with us

Quick Links

Our people
Case studies
Our thinking

Responsible Business
Diversity, Equity & Inclusion

About us
Careers
Contact us

Cookies
Disclaimer
Legal notices
Modern Slavery Statement
Privacy
RSS

© 2024 Hogan Lovells. All rights reserved. "Hogan Lovells" or the “firm” refers to the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses, each of which is a separate legal entity. Attorney advertising. Prior results do not guarantee a similar outcome.